Newsroom
September 1, 2016
The UT Horizon Fund recently invested $150,000 to fund Cardiovate, a San Antonio-based startup that is using technology from two University of Texas System institutions to commercialize a medical device to treat vascular diseases by repairing blood vessels. Read the full story at UTSA Today
August 20, 2016
An early stage San Antonio startup that aims to repair or replace clogged arteries with regenerated tissue has closed a small financing round from angel investors, The University of Texas Horizon Fund, and Targeted Technology, according to its CEO. Read the full story at Xconomy
May 25, 2016
People disabled by a stroke demonstrated substantial recovery long after the event when modified adult stem cells were injected into their brains. Read the full story at Stanford Medicine
May 9, 2016
Health Science Center experts weigh in on FDA’s new ruling on e-cigarettes.
May 6, 2016
Action by the U.S. Food and Drug Administration (FDA) May 5 to regulate e-cigarettes and vaping in the same way as cigarettes and smokeless tobacco is “a welcome step toward reducing the nation’s cancer burden,” said Ian M. Thompson Jr., M.D., director of the Cancer Therapy & Research Center (CTRC) at the Health Science Center. […]
April 25, 2016
Women had fewer deaths after transcatheter aortic valve replacement (TAVR) than men, despite near-doubled risk for in-hospital vascular complications, a late-breaking study here suggested. Read the full story at MedPage Today